Pharmacy OneSource Blog

Antimicrobial Use Reporting: Why It’s Important and How Hospitals Need to Prepare

Posted on 11/30/16

how-clinical_surveillance_impacts_clinical_pharmacists.jpg

It’s no secret that the national regulatory landscape is ramping up oversight of antimicrobial stewardship. An epidemic that is setting off global alarms, resistant organisms are wreaking havoc on patient safety and healthcare costs to the tune of 23,000 deaths and $34 billion annually.

Hospitals and health systems increasingly recognize the urgency and looking for ways to establish and optimize their antimicrobial stewardship initiatives. A number of facilities are already contributing to the solution by reporting antimicrobial usage information to stakeholders and the National Healthcare Safety Network (NHSN). While voluntary participation is a critical first step, current industry movements suggest there may be more at stake with reporting up the road.

Earlier this year, The Joint Commission issued a prepublication version of eight new performance standards for hospitals, critical access hospitals and nursing care centers that go into effect January 1, 2017. In tandem, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule that would also require hospitals to meet new performance criteria. These rules both address the need for methods of tracking antimicrobial usage.

Effective response requires that healthcare organizations have systems in place for accurate and efficient tracking of antimicrobial usage. For this reason, Sentri7® is introducing new capabilities to automate reporting to NHSN within its comprehensive antimicrobial stewardship offering.

While NHSN reporting is not specifically mandated in current regulatory initiatives, the expectation is that CMS is moving in that direction. Healthcare organizations that take a proactive stance with NHSN reporting as part of a greater antimicrobial stewardship program (ASP) can improve the outlook on resistant organisms and effectively position themselves for the future.

The Sentri7 Antimicrobial Stewardship offering automates manual processes of aggregating and reporting information on antimicrobial usage. This automatic data pull addresses detailed antimicrobial use, generates appropriate and enables one-click reporting to NHSN. As part of the greater Sentri7 clinical decision support surveillance solution, this new feature is easily integrated into EHR platforms.

In truth, clinical surveillance systems like Sentri7 are a proven best practice component for ASPs, providing the real-time tracking and identification of potential antimicrobial issues needed for proactive response. Healthcare organizations leveraging Sentri7 as part of a high-performing ASP are realizing significant return on investment that includes up to a 25% reduction in antimicrobial expenditures and a 35% decrease in antibiotic costs per patient day.

Come visit us at the 2016 ASHP Midyear Conference (Wolters Kluwer Booth #633) to learn how Sentri7’s intelligently filtered information built on customized rules prompts clinicians to respond proactively. We’ll share with you how hospitals across the nation are building high-performing ASPs and also demo our latest functionality for antimicrobial stewardship reporting.

clinical_surveillance_for_antimicrobial_stewardship

Topics: Antimicrobial Stewardship

About the Author

Deb Oroszlan is the Marketing Director for Pharmacy OneSource - Wolters Kluwer.